Compare Avantis US Small Cap Value ETF (AVUV) vs Cytokinetics Inc (CYTK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Avantis US Small Cap Value ETF vs Cytokinetics Inc — how do they compare? Avantis US Small Cap Value ETF trades at $127.95, while Cytokinetics Inc trades at $76.67 (market cap $10.63B). The key difference: Avantis US Small Cap Value ETF is trading nearer its 52-week high, Cytokinetics Inc nearer its low. Which is the better fit depends on your goals.
| AVUV | CYTK | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $128.74 | $87.26 |
52-Week Low | $93.93 | $34.31 |
Market Cap | — | $10.63B |
Enterprise Value | — | $10.74B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Avantis US Small Cap Value ETF
AVUV is an actively managed ETF that targets small-cap value companies in the United States. It uses a systematic, rules-based process to identify firms with low valuations and high profitability, aiming to capture the historical premiums of 'size' and 'value' while filtering for financial quality.
Read more on AVUV →About Cytokinetics Inc
Cytokinetics is a biopharmaceutical company focused on muscle biology. It develops muscle activators and inhibitors as potential treatments for debilitating diseases where muscle performance is compromised or declining.
Read more on CYTK →
